BioAge Labs BIOA
NASDAQ BIOA
$9.17 -0.23 (-2.40%)
As of: Sep 9, 2026 · 3:59 PM EDT

BioAge Labs (BIOA) Other Non-Current Assets (2023 - 2026)

BioAge Labs' (BIOA) quarterly Other Non-Current Assets came in at $208000.0 in Q2 2026, down 12.24% year-over-year from $237000.0 in Q2 2025, and down 3.26% quarter-over-quarter from $215000.0 in Q1 2026.

Analysis

BioAge Labs (BIOA) Other Non-Current Assets (2023 - 2026) Analysis & Trends

BioAge Labs has disclosed Other Non-Current Assets across 4 years of filings, most recently posting $208000.0 for Q2 2026.

  • In Q2 2026, Other Non-Current Assets fell 12.24% year-over-year to $208000.0; the TTM figure through Jun 2026 stood at $208000.0 (down 12.24% YoY), while the FY2025 annual figure was $216000.0, down 10.0% from the prior year.
  • Other Non-Current Assets came in at $208000.0 for Q2 2026 at BioAge Labs, down from $215000.0 in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $3.3 million in Q4 2023 to a low of $208000.0 in Q2 2026.
  • Average Other Non-Current Assets over 4 years is $610250.0, with a median of $232000.0 recorded in 2025.
  • Year-over-year, Other Non-Current Assets sank 92.73% in 2024 and decreased 10.0% in 2025.
  • Over 4 years, Other Non-Current Assets stood at $3.3 million in 2023, then slumped by 92.73% to $240000.0 in 2024, then slipped by 10.0% to $216000.0 in 2025, then slipped by 3.7% to $208000.0 in 2026.
  • Per Business Quant data, the three most recent Other Non-Current Assets figures were $208000.0 in Q2 2026, $215000.0 in Q1 2026, and $216000.0 in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn 12.98 Bn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn 4.75 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn 1.25 Bn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn 2.31 Bn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn 124.00 Mn
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn 618.00 Mn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn 65.13 Mn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn 831.80 Mn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn 104.44 Mn
10 BioAge Labs 439.00 Mn 439.00 Mn -14.23 Mn 208,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 208,000.00
Mar 31, 2026 215,000.00
Dec 31, 2025 216,000.00
Sep 30, 2025 227,000.00
Jun 30, 2025 237,000.00
Mar 31, 2025 239,000.00
Dec 31, 2024 240,000.00
Dec 31, 2023 3.30 Mn